Rahmer Peter's Form 4 filing
Relay Therapeutics, Inc. (RLAY) · filed Jul 1, 2024
- Accession no.
- 0000950170-24-079691
- Filed
- Jul 1, 2024
- Trade date
- Jun 27-30, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $1.53K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rahmer PeterCIK 0001959229 | Officer (See remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 27, 2024 | Common Stock | SSaleDisposed | −245 | $6.26 | −$1,533.7 | 432,180 | Direct | |
| Jun 30, 2024 | Common Stock | AGrant or awardAcquired | +2,108 | $5.54F4 | +$11,678.32 | 434,288 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 28, 2024.
Referenced by the price of 1 transaction in Table I.
Remarks
Chief Corporate Development Officer